RE: Just bought some12 Jan 2026 17:43
I suppose the next update could be any of these… very promising
“The Way Ahead"
Our immediate goals are:
· To focus on growing orders of EpiSwitch PSE (targeting 500 tests/month within 12 months).
· To out‑license or partner a test (CiRT, NST and ME/CFS representing the most likely candidates for out-licensing).
· To sign a distribution deal/partnership on the PSE test, securing an upfront fee, ongoing milestone payments and royalties on sales.
· To establish EpiSwitch CiRT in NCCN Guidelines and thereafter to seek partners for the test.
· To build on the agreement with Google Cloud to directly monetise the Company's 3D genomics platform and knowledgebase, through the forthcoming EpiSwitch® Orion cloud platform.
· To contract and deliver projects for pharma and other customers through sustained direct business development initiatives and/or via leads arising from the use of the platform and knowledgebase.